11. Three signal studies were published in 2018 that shed new light on the net clinical benefit of ASA in primary prevention of CV events. These were:
a. ACUITY, ABOARD, ABSORB
b. ARRIVE, ASCEND, ASPREE
c. ASPREE, ACCORD, ACTIVATE
d. ASCEND, ACTION, APEX
You answered A. Your answer was incorrect. B is the correct answer.
EXPLANATION: Only choice (b) is correct. ARRIVE = Aspirin to Reduce Risk of Initial Vascular Events; ASCEND = A Study of Cardiovascular Events in Diabetes; ASPREE = Aspirin in Reducing Events in the Elderly.